ROSEMONT, Pennsylvania (Press Release) — Duchesnay USA has received Kosher and Halal certifications for Diclegis® (doxylamine succinate 10mg and pyridoxine hydrochloride -vitamin B6– 10mg) delayed-release tablets, the only FDA-approved prescription treatment for nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness. Diclegis also received Kosher for Passover certification and confirmed as gluten, lactose and tartrazine free, making the product accessible for women suffering from celiac disease or gluten and lactose intolerance.[1]
“Duchesnay USA’s ultimate goal is to provide access to safe and effective treatments to pregnant women. This includes meeting the specific needs of pregnant women of all cultural and religious backgrounds as well as those that may have dietary restrictions,” said Eric Gervais, Executive Vice President of Duchesnay Inc.
Duchesnay USA received its Kosher and Passover certification from the Kashruth Council of Canada (COR): Kosher Certification Agency and Halal certification from the Islamic Society of North America (ISNA®) Halal Certification Agency. These certifications, which were granted by well recognized and independent organizations, determine whether products are being manufactured according to specific high standards of preparation and selection of ingredients.
For more information about Diclegis®, visit www.Diclegis.com.
*
Preceding provided by Ducehsnay USA